upseed
Browse programs

Organization · Venture Capital

KELES

KELES is a venture capital firm based in Luxembourg, focused on investing in growth-stage digital health and techbio companies across Europe. The firm aims to bridge the funding gap for companies approaching scale-up inflection points.

Venture CapitalFunder
Official website (opens in a new tab)

Overview

What KELES does

What KELES is

KELES is a venture capital firm based in Luxembourg, focused on investing in growth-stage digital health and techbio companies across Europe. The firm aims to bridge the funding gap for companies approaching scale-up inflection points.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Venture Capital
Founded
Founded in 2024
Approximate age
About 2 years
Structured capabilities
Funder
Last reviewed
March 27, 2026

Official channels

Find KELES elsewhere

Open the official website or a supported primary organization account.

Capability profile

KELES as a funder

Check pitch availability (opens in a new tab)

Investment thesis

KELES fills a specific structural gap in European health venture by targeting digital health companies that have proven products and initial commercial traction but struggle to access larger growth capital needed for international scaling.

Focus narrative

KELES invests in growth-stage companies that have demonstrated profitability and are at a scaling inflection point. The firm targets high-potential regions in Europe where innovation thrives but funding is limited, focusing on segments such as R&D, diagnostics, AI imaging, digital medtech, and patient care. Their investment strategy emphasizes leveraging technology and AI to transform healthcare and improve patient outcomes.

Terms and economics

Typical check
$8,000,000–$30,000,000

Focus and fit

Stages
Growth Equity
Regions
Europe

Availability

Currently deploying
Not published

Connected ecosystem

Continue from KELES

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Same organization type

AccelSame type: Venture Capital · FunderAndreessen HorowitzSame type: Venture Capital · Funder · PublisherGeneral CatalystSame type: Venture Capital · Funder · Event host · PublisherBessemer Venture PartnersSame type: Venture Capital · Funder · Publisher

Structured sector focus

Healthcare14,287 funders · 158 programsArtificial Intelligence9,945 funders · 144 programsBiotech & Life Sciences5,717 funders · 79 programsDigital Health1,029 funders · 16 programs

Structured regional focus

EuropeContinent · 12,949 organizations

Common questions

What to know about KELES

Upseed classifies KELES under the Venture Capital organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Browse organizationsExplore Healthcare

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 27, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Official website Suggest a correction

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.